SEA4US
A world-class biotechnology company in marine pharmaceutical research and development that aims to discover treatments to respond to unmet clinical needs.
Sea4Us has secured funding through the Accelerator Program from the European Innovation Council and SMEs Executive Agency (EISMEA).
EIC’s support not only showcases Sea4Us’ technological breakthrough but takes us closer to delivering our novel and highly effective #analgesic to #chronic #pain patients. With the 2.5M€ in Grant, from an investment opportunity with EIF (European Investment Fund) of up to 5.96M€ we will change the lives of billions of people worldwide!
The funding received will be crucial in taking our #nonopioid treatment to IND and clinical trials.
Chronic pain affects 1.6 billion people worldwide, which have either ineffective or unsafe treatments available.
Our #marineinspired novel #analgesic will allow for #safe and #effective treatment, without the associated serious side-effects seen with most available solutions.
We extend our congratulations to PICadvanced and TargTex, who have also achieved great success within the EIC program; and ANI | Agência Nacional de Inovação for the support.
A world-class biotechnology company in marine pharmaceutical research and development that aims to discover treatments to respond to unmet clinical needs.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.